Understanding and categorizing the various types of tubulointerstitial responses in acute kidney injury (AKI) may lead to the ...

et al. Treatment and Outcomes of Terlipressin in Hospitalized Adults with Hepatorenal Syndrome-Acute Kidney Injury (HRS-AKI): Real-world Evidence in Patients by Transplant Waitlist Status.

There are currently no proven therapies that reduce cisplatin-induced acute kidney injury (AKI) in patients with cancer.

Five presentations highlight TERLIVAZ research in adults with HRS with rapid reduction in kidney function, 1 also known as HRS-AKI 2 – Abstract #4243460: Treatment and Outcomes of Terlipressin ...